trending Market Intelligence /marketintelligence/en/news-insights/trending/yKB0fDH1dSeRrIAvQZWUbg2 content esgSubNav
In This List

Loxo Oncology director resigns

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Loxo Oncology director resigns

David Bonita resigned as a class II independent director of Loxo Oncology Inc., effective Dec. 22.

Bonita's resignation is not the result of any disagreement with the company on any matter relating to its operations, policies or practices.